Expert Consensus on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Gastroesophageal Reflux Disease(2025)
-
摘要: 胃食管反流病是一种常见的消化系统疾病，发病率高且易反复。为协助临床医生对该病进行精确、科学的诊断与有效治疗，本共识综合中医与西医视角，详尽阐述了胃食管反流病的临床特点、诊断方法及治疗手段的最新进展，旨在为医护人员提供一个全面、深入的参考框架，以优化胃食管反流病的诊疗策略。Abstract: Gastroesophageal reflux disease is a common digestive system disease with a high incidence rate and easy recurrence. To assist clinical doctors in accurate and scientific diagnosis and effective treatment of gastroesophageal reflux disease, this consensus comprehensively elaborates on the latest progress in understanding, diagnostic methods, and treatment methods of gastroesophageal reflux disease from the perspectives of traditional and western medicine, aiming to provide a comprehensive and in-depth reference framework for medical staff to optimize the diagnosis and treatment strategies of gastroesophageal reflux disease.
-
-
[1] 李军祥, 陈誩, 李岩. 胃食管反流病中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志, 2018, 26(3): 221-226, 232. doi: 10.3969/j.issn.1671-038X.2018.03.01
[2] Eusebi LH, Ratnakumaran R, Yuan YH, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis[J]. Gut, 2018, 67(3): 430-440. doi: 10.1136/gutjnl-2016-313589
[3] Jung HK, Tae CH, Song KH, et al. 2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease[J]. J Neurogastroenterol Motil, 2021, 27(4): 453-481. doi: 10.5056/jnm21077
[4] 陈旻湖, 杨云生, 唐承薇. 消化病学[M]. 北京: 人民卫生出版社, 2019: 73-90.
[5] 中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J]. 中华消化杂志, 2020, 40(10): 649-663. doi: 10.3760/cma.j.cn311367-20200918-00558
[6] Broderick R, Fuchs KH, Breithaupt W, et al. Clinical presentation of gastroesophageal reflux disease: a prospective study on symptom diversity and modification of questionnaire application[J]. Dig Dis, 2020, 38(3): 188-195. doi: 10.1159/000502796
[7] 汪忠镐, 吴继敏, 胡志伟, 等. 中国胃食管反流病多学科诊疗共识[J]. 中华胃食管反流病电子杂志, 2020, 7(1): 1-28. doi: 10.3877/cma.j.issn.2095-8765.2020.01.001
[8] Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development[J]. Gastroenterology, 1996, 110(6): 1982-1996. doi: 10.1053/gast.1996.1101982
[9] Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon consensus[J]. Gut, 2018, 67(7): 1351-1362. doi: 10.1136/gutjnl-2017-314722
[10] Farré R, Blondeau K, Clement D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique[J]. Gut, 2011, 60(7): 885-892. doi: 10.1136/gut.2010.233049
[11] Frazzoni M, de Bortoli N, Frazzoni L, et al. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring[J]. Neurogastroenterol Motil, 2017, 29(3): e12947. doi: 10.1111/nmo.12947
[12] Gyawali CP, Sifrim D, Carlson DA, et al. Ineffective esophageal motility: Concepts, future directions, and conclusions from the Stanford 2018 symposium[J]. Neurogastroenterol Motil, 2019, 31(9): e13584. doi: 10.1111/nmo.13584
[13] Gyawali CP, Roman S, Bredenoord AJ, et al. Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group[J]. Neurogastroenterol Motil, 2017, 29(12): e13104. doi: 10.1111/nmo.13104
[14] Oh TH. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the diamond study(gut 2010;59: 714-721)[J]. J Neurogastroenterol Motil, 2011, 17(1): 98-99. doi: 10.5056/jnm.2011.17.1.98
[15] de Bortoli N, Guidi G, Martinucci I, et al. Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study[J]. Dis Esophagus, 2016, 29(2): 197-204. doi: 10.1111/dote.12319
[16] Ness-Jensen E, Lindam A, Lagergren J, et al. Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study[J]. Am J Gastroenterol, 2013, 108(3): 376-382. doi: 10.1038/ajg.2012.466
[17] Yuan LZ, Yi P, Wang GS, et al. Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China[J]. Therap Adv Gastroenterol, 2019, 12: 1756284819877788. doi: 10.1177/1756284819877788
[18] Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle intervention in gastroesophageal reflux disease[J]. Clin Gastroenterol Hepatol, 2016, 14(2): 175-182. e1-3. doi: 10.1016/j.cgh.2015.04.176
[19] Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2013, 108(3): 308-328;quiz 329. doi: 10.1038/ajg.2012.444
[20] Chen SF, Liu DL, Chen HH, et al. The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: a phase Ⅲ, randomised, double-blind multicentre study[J]. Aliment Pharmacol Ther, 2022, 55(12): 1524-1533. doi: 10.1111/apt.16959
[21] Oshima T, Arai E, Taki M, et al. Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis[J]. Aliment Pharmacol Ther, 2019, 49(2): 140-146. doi: 10.1111/apt.15062
[22] Kinoshita Y, Hongo M. Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: the Japan-based TWICE study[J]. Am J Gastroenterol, 2012, 107(4): 522-530. doi: 10.1038/ajg.2012.19
[23] Khan Z, Alastal Y, Khan MA, et al. On-demand therapy with proton pump inhibitors for maintenance treatment of nonerosive reflux disease or mild erosive esophagitis: a systematic review and meta-analysis[J]. Gastroenterol Res Pract, 2018, 2018: 6417526.
[24] Tang YP, Li PC, Liu X, et al. A single-center retrospective study on epidemiological and Traditional Chinese Medicine syndrome characteristics of 21010 patients with reflux/heartburn symptoms[J]. J Tradit Chin Med, 2023, 43(3): 574-581.
[25] 唐艳萍, 李培彩. 胃食管反流病合并情绪障碍的研究现状与诊治策略[J]. 中国中西医结合消化杂志, 2023, 31(7): 497-503. doi: 10.3969/j.issn.1671-038X.2023.07.03
[26] 孔凯, 杨正武. 氟哌噻吨美利曲辛辅助治疗难治性胃食管反流病疗效及安全性meta分析[J]. 现代医药卫生, 2020, 36(13): 1964-1969. doi: 10.3969/j.issn.1009-5519.2020.13.004
[27] Weijenborg PW, de Schepper HS, Smout AJPM, et al. Effects of antidepressants in patients with functional esophageal disorders or gastroesophageal reflux disease: a systematic review[J]. Clin Gastroenterol Hepatol, 2015, 13(2): 251-259. e1. doi: 10.1016/j.cgh.2014.06.025
[28] Si XB, Huo LY, Bi DY, et al. Comparative efficacy of antidepressants for symptoms remission of gastroesophageal reflux: a Bayesian network meta-analysis of randomized controlled trials[J]. Turk J Gastroenterol, 2021, 32(10): 843-853. doi: 10.5152/tjg.2021.20607
[29] 中国医师协会消化医师分会胃食管反流病专业委员会, 中华医学会消化内镜学分会食管疾病协作组. 2020年中国胃食管反流病内镜治疗专家共识[J]. 中华消化内镜杂志, 2021, 38(1): 1-12. doi: 10.3760/cma.j.cn321463-20201115-00897
[30] Fass R, Cahn F, Scotti DJ, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease[J]. Surg Endosc, 2017, 31(12): 4865-4882. doi: 10.1007/s00464-017-5431-2
[31] Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler(MUSETM)for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial[J]. Surg Endosc, 2015, 29(1): 220-229. doi: 10.1007/s00464-014-3731-3
[32] Kim HJ, Kwon CI, Kessler WR, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSETM endoscopic stapling device[J]. Surg Endosc, 2016, 30(8): 3402-3408. doi: 10.1007/s00464-015-4622-y
[33] Yoo IK, Ko WJ, Kim HS, et al. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study[J]. Surg Endosc, 2020, 34(3): 1124-1131. doi: 10.1007/s00464-019-06859-y
[34] 吴继敏. 抗反流外科在中国的发展及展望[J]. 中华普通外科杂志, 2022, 37(2): 81-83.
[35] Park Y, Aye RW, Watkins JR, et al. Laparoscopic hill repair: 25-year follow-up[J]. Surg Endosc, 2018, 32(10): 4111-4115. doi: 10.1007/s00464-018-6150-z
[36] 张瑞, 李治仝, 刘福荣, 等. 腹腔镜新型抗反流手术治疗胃食管反流病合并食管裂孔疝的疗效分析[J]. 中华普通外科杂志, 2020, 35(12): 943-946. doi: 10.3760/cma.j.cn113855-20200521-00412
[37] 胡志伟, 吴继敏, 汪忠镐, 等. 腹腔镜新型W-H胃底折叠术治疗质子泵抑制剂依赖性胃食管反流病疗效分析[J]. 中华医学杂志, 2021, 101(10): 737-743. doi: 10.3760/cma.j.cn112137-20200622-01920
[38] Zhuang QJ, Tan ND, Chen SF, et al. Magnetic sphincter augmentation in treating refractory gastroesophageal reflux disease: a systematic review and meta-analysis[J]. J Dig Dis, 2021, 22(12): 695-705. doi: 10.1111/1751-2980.13063
[39] Guidozzi N, Wiggins T, Ahmed AR, et al. Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis[J]. Dis Esophagus, 2019, 32(9): doz031. doi: 10.1093/dote/doz031
[40] 谢胜, 黎丽群, 钟碧焕, 等. 7种中药方治疗肝胃不和型胃食管反流病的网状Meta分析[J]. 辽宁中医杂志, 2019, 46(9): 1793-1798.
[41] 达礼, 梁丽, 陈宏纲, 等. 胃苏颗粒联合雷贝拉唑肠溶片治疗胃食管反流病的临床研究[J]. 中外医学研究, 2019, 17(29): 33-35.
[42] 翟晓刚, 刘彩霞, 马荣炜, 等. 胃苏颗粒联合奥美拉唑对反流性食管炎患者的疗效分析[J]. 辽宁中医杂志, 2021, 48(10): 132-135.
[43] 魏堰翀, 刘富林, 朱哲琴, 等. 气滞胃痛颗粒联合质子泵抑制剂治疗反流性食管炎的Meta分析[J]. 广西中医药大学学报, 2022, 25(1): 77-82.
[44] 唐茶娣. 大柴胡汤合左金丸联合针刺治疗肝胃郁热型难治性胃食管反流病36例观察[J]. 浙江中医杂志, 2019, 54(9): 646-647. doi: 10.3969/j.issn.0411-8421.2019.09.015
[45] 王洪双, 王石红, 李喆, 等. 左金丸加减治疗肝胃郁热型胃食管反流病的系统评价[J]. 云南中医学院学报, 2020, 43(6): 18-25.
[46] 刘全喜, 陈亮, 贾玉, 等. 旋覆代赭汤合六君子汤联合雷贝拉唑钠肠溶胶囊治疗反流性食管炎中虚气逆证临床观察[J]. 河北中医, 2021, 43(8): 1332-1336, 1345. doi: 10.3969/j.issn.1002-2619.2021.08.023
[47] 盛松, 高洪阳, 黄烨, 等. 枳术宽中胶囊辅助治疗胃食管反流病的Meta分析和试验序贯分析[J]. 中国中西医结合消化杂志, 2021, 29(4): 256-262. doi: 10.3969/j.issn.1671-038X.2021.04.06
[48] 许永攀, 王捷虹, 田正良. 甘海胃康胶囊联合西药治疗胃食管反流病56例[J]. 陕西中医, 2013, 34(1): 22-23.
[49] 孔宪志. 半夏厚朴汤合黄连温胆汤加减治疗反流性食管炎26例临床观察[J]. 江苏中医药, 2012, 44(12): 46-47.
[50] 李淑红, 唐艳萍, 李淑云. 雷贝拉唑联合吗丁啉联合香砂平胃颗粒治疗反流性食管炎的临床疗效观察[J]. 湖南中医药大学学报, 2010, 30(4): 21-22.
[51] 田明, 孙清露. 血府逐瘀汤联合艾司奥美拉唑镁肠溶片对胃食管反流病气滞血瘀证的疗效观察[J]. 中华胃食管反流病电子杂志, 2020, 7(3): 139-143.
[52] 张媛, 李永娟, 崔云凤, 等. 荜铃胃痛颗粒联合雷贝拉唑治疗对胃食管反流病临床效果、症候积分及GERDQ评分的影响[J]. 解放军医药杂志, 2022, 34(5): 125-128.
[53] 朱淑云. 半夏泻心汤加味方配合针灸治疗胃食管反流病寒热错杂型的疗效及对中医证候、生活质量的影响[J]. 中国全科医学, 2019, 22(S2): 177-179.
[54] 刘建茹. 荆花胃康胶丸联合质子泵抑制剂对治疗胃食管反流病的效果及炎性因子的影响[J]. 黑龙江医药, 2020, 33(6): 1309-1311.
[55] Zhu JJ, Guo Y, Liu S, et al. Acupuncture for the treatment of gastro-oesophageal reflux disease: a systematic review and meta-analysis[J]. Acupunct Med, 2017, 35(5): 316-323.
[56] 李彬, 白辉辉, 张一. 热敏灸配合质子泵抑制剂治疗胃食管反流性咳嗽疗效观察[J]. 上海针灸杂志, 2019, 38(6): 597-600.
[57] 孟羽, 李丰, 何晓晖, 等. 穴位热敏灸治疗胃食管反流病的临床研究[J]. 针灸临床杂志, 2011, 27(2): 41-42.
[58] 宋庆增, 谢胜, 戴文杰, 等. 督脉经针刺及穴位埋线治疗胃食管反流病的Meta分析[J]. 中国中医基础医学杂志, 2020, 26(7): 959-962.
[59] 李建锋, 谢胜, 李娟, 等. 指针疗法治疗胃食管反流病的Meta分析[J]. 辽宁中医杂志, 2019, 46(4): 819-824.
-
下载:
计量
- 文章访问数: 486
- 施引文献: 0